創傷ケア用バイオロジクスの世界市場レポート 2024年

創傷ケア用バイオロジクスの市場規模は近年力強く成長しています。2023年の17億6,000万米ドルから2024年には19億3,000万米ドルへと、CAGR9.5％で拡大します。過去数年間に見られた拡大は、臨床的エビデンスや調査の存在、規制枠組みの開拓、創傷ケア市場の進化、限られた治療オプションの存在、研究開発努力などが背景にあります。

創傷ケア用バイオロジクス市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.8％で27億1,000万米ドルに成長します。予測期間中に予想される拡大は、個別化医療への注目の高まり、ヘルスケア支出の増加、価値ベースのヘルスケアモデルの採用、先進的治療への需要の高まり、支援的な規制措置や承認によるものと考えられます。予測期間中に予想される主な動向には、再生医療の重視、生体工学的皮膚代替物の利用、革新的デリバリーシステムの導入、慢性創傷管理の増加、患者中心のケアへの取り組みなどが含まれます。

近い将来に予想される創傷ケア用バイオロジクス市場の成長は、糖尿病の高い有病率によって促進されると予想されます。血糖値の上昇を特徴とする糖尿病は、時間の経過とともに心臓、血管、目、腎臓、神経に大きなダメージを与えます。創傷ケア用バイオロジクスは、糖尿病に伴う揮発性水分損失、熱損失、タンパク質および電解質の損失、汚染を防ぐ上で重要な役割を果たします。また、自己溶解性剥離を促進し、顆粒状の創傷層を形成します。IDF糖尿病アトラス第10版2021年報告書では、2021年の糖尿病患者数（20～79歳）を5億3,700万人と推定しています。2030年には6億4,300万人、2045年には7億8,300万人に増加すると予測されており、糖尿病が創傷ケア用バイオロジクス市場に与える影響が強調されています。

創傷ケア用バイオロジクス市場の成長は、外科手術の増加によって促進されると予測されています。外科的処置には、様々な病状に対処するための切開や器具の使用を含む医療介入が含まれます。創傷ケア用バイオロジクスは、生きた細胞、成長因子、その他の生物学的材料から成り、自然治癒プロセスに貢献します。外科手術の急増により、手術創の治癒を早め、合併症を最小限に抑え、患者の転帰全体を改善することを目的とした先進的創傷ケアソリューションへの関心が高まっています。例えば、経済協力開発機構によると、チェコ共和国では白内障手術件数が8.4％増加し、2021年の131,612件に対し、2022年には142,670件となった。このような手術件数の急増は、創傷ケア用バイオロジクス市場の成長の原動力となっています。

2023年の創傷ケア用バイオロジクス市場で最大の地域は北米でした。アジア太平洋は、創傷ケア用バイオロジクスの世界市場レポートにおいて、予測期間中に最も急成長する地域となる見込みです。創傷ケア用バイオロジクス市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の創傷ケア用バイオロジクス市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 生物学的皮膚代替品
• 外用剤
• 世界の創傷ケア用バイオロジクス市場、創傷タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 潰瘍
• 外科手術
• 外傷性の傷
• 熱傷
• 世界の創傷ケア用バイオロジクス市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 外来手術センター（ACS）
• 熱傷センター
• 創傷クリニック

第7章 地域および国の分析

• 世界の創傷ケア用バイオロジクス市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の創傷ケア用バイオロジクス市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 創傷ケア用バイオロジクス市場の競合情勢
• 創傷ケア用バイオロジクス市場の企業プロファイル
  • Integra Lifesciences Corporation
  • Organogenesis Inc.
  • Smith and Nephew plc
  • Wright Medical Group NV
  • MiMedx Group Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Wound Care Biologics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wound care biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wound care biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The wound care biologics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Biologic Skin Substitutes; Topical Agents
• 2) By Wound Type: Ulcers; Surgical; Traumatic Wounds; Burns
• 3) By End User: Hospitals; Ambulatory Surgery Center (ACS); Burn Centers; Wound Clinics
• Companies Mentioned: Integra Lifesciences Corporation; Organogenesis Inc.; Smith and Nephew plc; Wright Medical Group NV; MiMedx Group Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Wound care biologics refer to bioengineered products specifically designed for the treatment of non-healing wounds in the lower extremity. These biologics are gaining prominence in wound care due to their effective control of secretions and protective properties against bacterial infections.

The primary products within the field of wound care biologics include biologic skin substitutes and topical agents. Biologic skin substitutes play a crucial role in wound healing and have proven to be highly beneficial within the medical industry. Also known as tissue-engineered products or artificial skin, biologic skin substitutes are biological substances that facilitate wound healing by promoting the generation of new tissues. Wound care biologics are commonly utilized to treat various types of wounds, including ulcers, surgical wounds, traumatic wounds, and burns. The end users of these biologics include hospitals, Ambulatory Surgical Centers (ASCs), burn centers, and wound clinics.

The wound care biologics software market research report is one of a series of new reports from The Business Research Company that provides wound care biologics software market statistics, including wound care biologics software industry global market size, regional shares, competitors with a wound care biologics software market share, detailed wound care biologics software market segments, market trends and opportunities, and any further data you may need to thrive in the wound care biologics software industry. This wound care biologics software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wound care biologics market size has grown strongly in recent years. It will grow from $1.76 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The expansion observed in the historical period can be credited to the presence of clinical evidence and studies, the development of regulatory frameworks, the evolution of the wound care market, the existence of limited treatment options, and concerted research and development efforts.

The wound care biologics market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated expansion in the forecast period can be ascribed to a heightened focus on personalized medicine, an increase in healthcare expenditure, the adoption of value-based healthcare models, a growing demand for advanced therapies, and supportive regulatory measures and approvals. Major trends expected in the forecast period encompass an emphasis on regenerative medicine, the utilization of bioengineered skin substitutes, the introduction of innovative delivery systems, a rise in chronic wound management, and a commitment to patient-centric care.

The anticipated growth of the wound care biologics market in the near future is expected to be propelled by the high prevalence of diabetes. Diabetes, characterized by elevated blood glucose levels, leads to significant damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Wound care biologics play a crucial role in preventing volatile water loss, heat loss, protein and electrolyte loss, and contamination associated with diabetes. They also facilitate autolytic debridement and generate a granular wound layer. The market is driven by the substantial prevalence of diabetes, as highlighted in the IDF Diabetes Atlas Tenth Edition 2021 report, which estimated 537 million individuals (20-79 years old) with diabetes in 2021. The projections indicate a rise to 643 million by 2030 and 783 million by 2045, underscoring the impact of diabetes on the wound care biologics market.

The growth of the wound care biologics market is expected to be fueled by the increasing number of surgical procedures. Surgical procedures involve medical interventions that include incisions or the use of instruments to address various medical conditions. Wound care biologics, comprising living cells, growth factors, or other biological materials, contribute to the natural healing process. The surge in surgical procedures has heightened interest in advanced wound care solutions, aiming to expedite the healing of surgical wounds, minimize complications, and improve overall patient outcomes. For example, the Czech Republic witnessed an 8.4% increase in cataract surgical procedures, totaling 142,670 procedures in 2022 compared to 131,612 in 2021, according to the Organization for Economic Co-operation and Development. This surge in surgical procedures serves as a driving force for the growth of the wound care biologics market.

Product innovation stands out as a prominent trend gaining traction in the consumer and wound care biologics market. Leading companies in the wound care biologics sector are strategically focusing on the development of innovative products infused with advanced technologies to bolster their market positions. For instance, in April 2021, Kerecis, a US-based company specializing in treating wounds, burns, and complex acute and chronic wounds, introduced the Kerecis Omega3 GraftGuide. This fish skin product, approved by the FDA under the 510(k) regulatory procedure, addresses the challenges associated with burn healing. It enhances autograft take, reduces the necessity for autograft harvesting, and serves as an alternative to autografting.

Skin graft development is a major focus for key companies in the wound care biologics market, aiming to gain a competitive edge. Skin grafting involves a surgical procedure where healthy skin is transplanted from one body area (donor site) to another area that has lost its protective covering due to injury, surgery, burns, or other traumatic conditions. For instance, in July 2022, Tides Medical, a US-based biotechnology company, launched Artacent AC, a tri-layer skin graft designed for treating complex or challenging wounds. With a three-layer structure (amnion-chorion-amnion), it surpasses traditional dual-layer products, being three times stronger and two times thicker. Artacent AC is developed to enhance handling and application to wound sites, offering clinicians an improved solution for complex patient wounds in various medical conditions such as diabetic foot ulcers, chronic wounds, burns, Mohs surgery, and other surgical applications. The product boasts a longer shelf life at room temperature, eliminating the need for refrigeration, and can be placed on either side facing the wound.

In December 2021, Essity AB, a Sweden-based hygiene and health company specializing in one-use products such as compression therapy, orthopedics, and wound care, acquired Hydrofera for $116 million. This strategic acquisition aligns with Essity's goal of expansion through acquisitions in the Medical Solutions sector. Hydrofera, a US-based company, offers antibacterial wound dressings and an advanced line of wound care products.

Major companies operating in the wound care biologics market report are Integra Lifesciences Corporation, Organogenesis Inc., Smith and Nephew plc, Wright Medical Group NV, MiMedx Group Inc., Kerecis AG, Amnio Technology LLC, Anika Therapeutics Inc., ACell Inc., Derma Sciences Inc., Soluble Systems Pvt. Ltd., Medline Industries LP, Solsys Medical LLC, Zimmer Biomet Holdings Inc., MLM Biologics Inc., Tissue Genesis LLC, Stryker Corporation, Marine Polymer Technologies Inc., Bioventus Inc., Molnlycke Health Care AB, Lynch Biologics LLC, Skye Biologics Holdings LLC, Osiris Therapeutics Inc., Vericel Corporation, TissueTech Inc., PolarityTE Inc., Avita Medical Limited, Celularity Inc., Human Regenerative Technologies LLC, PolyRemedy Inc.

North America was the largest region in the wound care biologics market in 2023. Asia-pacific is expected to be the fastest-growing region in the global wound care biologics market report during the forecast period. The regions covered in the wound care biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the wound care biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The wound care biologics market consists of revenues earned by entities by providing wound care services such as surgical and traumatic wounds, burns chronic wounds and acute Wounds. The market value includes the value of related goods sold by the service provider or included within the service offering. The wound care biologics market also includes sales of surgical equipment's, medical tape, sponges, cotton pads which are used in providing wound care biologics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Wound Care Biologics Market Characteristics

3. Wound Care Biologics Market Trends And Strategies

4. Wound Care Biologics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Wound Care Biologics Market Size and Growth

• 5.1. Global Wound Care Biologics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Wound Care Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Wound Care Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Wound Care Biologics Market Segmentation

• 6.1. Global Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Biologic Skin Substitutes
• Topical Agents
• 6.2. Global Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Ulcers
• Surgical
• Traumatic Wounds
• Burns
• 6.3. Global Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgery Center (ACS)
• Burn Centers
• Wound Clinics

7. Wound Care Biologics Market Regional And Country Analysis

• 7.1. Global Wound Care Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Wound Care Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Wound Care Biologics Market

• 8.1. Asia-Pacific Wound Care Biologics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Wound Care Biologics Market

• 9.1. China Wound Care Biologics Market Overview
• 9.2. China Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Wound Care Biologics Market

• 10.1. India Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Wound Care Biologics Market

• 11.1. Japan Wound Care Biologics Market Overview
• 11.2. Japan Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Wound Care Biologics Market

• 12.1. Australia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Wound Care Biologics Market

• 13.1. Indonesia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Wound Care Biologics Market

• 14.1. South Korea Wound Care Biologics Market Overview
• 14.2. South Korea Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Wound Care Biologics Market

• 15.1. Western Europe Wound Care Biologics Market Overview
• 15.2. Western Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Wound Care Biologics Market

• 16.1. UK Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Wound Care Biologics Market

• 17.1. Germany Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Wound Care Biologics Market

• 18.1. France Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Wound Care Biologics Market

• 19.1. Italy Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Wound Care Biologics Market

• 20.1. Spain Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Wound Care Biologics Market

• 21.1. Eastern Europe Wound Care Biologics Market Overview
• 21.2. Eastern Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Wound Care Biologics Market

• 22.1. Russia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Wound Care Biologics Market

• 23.1. North America Wound Care Biologics Market Overview
• 23.2. North America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Wound Care Biologics Market

• 24.1. USA Wound Care Biologics Market Overview
• 24.2. USA Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Wound Care Biologics Market

• 25.1. Canada Wound Care Biologics Market Overview
• 25.2. Canada Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Wound Care Biologics Market

• 26.1. South America Wound Care Biologics Market Overview
• 26.2. South America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Wound Care Biologics Market

• 27.1. Brazil Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Wound Care Biologics Market

• 28.1. Middle East Wound Care Biologics Market Overview
• 28.2. Middle East Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Wound Care Biologics Market

• 29.1. Africa Wound Care Biologics Market Overview
• 29.2. Africa Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Wound Care Biologics Market Competitive Landscape And Company Profiles

• 30.1. Wound Care Biologics Market Competitive Landscape
• 30.2. Wound Care Biologics Market Company Profiles
  • 30.2.1. Integra Lifesciences Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Organogenesis Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Smith and Nephew plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Wright Medical Group NV
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. MiMedx Group Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Wound Care Biologics Market Competitive Benchmarking

32. Global Wound Care Biologics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Wound Care Biologics Market

34. Wound Care Biologics Market Future Outlook and Potential Analysis

• 34.1 Wound Care Biologics Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Wound Care Biologics Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Wound Care Biologics Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer